Found 120 matching trials
NAPOLI-2: Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Biliary Cancer PHASE2 This is a study to evaluate the clinical activity of the combination of flu...
Show More Status
Active Not Recruiting
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study PHASE2 This is an investigator-initiated, prospective, multicenter, single-arm pha...
Show More Location
Tianjin Medical University Cancer Institute and Hospital
Learn More & Join Trial
A Study of the Safety and Activity of Liposomal Irinotecan in Combination With the 5-FU and Oxaliplatin in the Preoperative Treatment of Pancreatic Adenocarcinoma PHASE2 This is a phase II, single arm, non-randomized, open label study of liposom...
Show More Status
Active Not Recruiting
Location
University of Florida
Learn More & Join Trial
Nal-IRI(Nanoliposomal Irinotecan) Plus 5-FU/LV in Metastatic Biliary Tract Cancer PHASE2 The purpose of this study is to evaluate the efficacy and safety of combina...
Show More Location
Asan Medical Center
Learn More & Join Trial
Clinical Trial of VIM With VIT in Children With Relapsed and Refractory Soft Tissue Sarcoma. PHASE2 Explore the efficacy and safety of mitoxantrone liposome combined with irin...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Newly Emerging Immunotherapy for Pancreatic Cancer Treatment PHASE1 This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Show More Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Learn More & Join Trial
Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial PHASE2 This is a prospective, Bayesian adaptive, phase II clinical trial designed ...
Show More Location
Cancer Center of Guangzhou Medical University
Learn More & Join Trial
Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma PHASE2 The purpose of this study is to assess objective tumor response in the sing...
Show More Location
Clinical Hospital Mostar
Learn More & Join Trial
Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM) PHASE2 The study is a phase II with safety lead in, single arm, study using Nal-IR...
Show More Location
Multiple Locations
Learn More & Join Trial